A typical dosage you will find is 1,500mg
The Regulatory Reality of 2026: What Actually Changed In late 2023, the FDA moved 19 peptides, including BPC-157, to what's known as "Category 2" status under its framework for bulk drug substances used in compounding, identifying them as substances that "may present significant safety risks." The concern, as stated in FDA guidance, centered on the limited large-scale human data and questions about immunogenicity
Drugmakers argue the shortages are over and the FDA correctly relied on supply data, while compounders say the agency rushed its decision, ignored evidence of ongoing shortages, and used an improper legal process
This simple habit can save you from a world of frustration
Wegovy is given as an injection under the skin once weekly